Coenzyme Q10 supplementation improves acute outcomes of stroke in rats pretreated with atorvastatin

References

• Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke. 2014;45(7):2160–236.
   PubMed Web of Science ®Google Scholar
• Gargano JW, Wehner S, Reeves MJ. Presenting symptoms and onset-to-arrival time in patients with acute stroke and transient ischemic attack. J Stroke Cerebrovas Dis. 2011;20(6):494–502.
   PubMed Web of Science ®Google Scholar
• García-Bonilla L, Campos M, Giralt D, Salat D, Chacón P, Hernández-Guillamon M, et al. Evidence for the efficacy of statins in animal stroke models: a meta-analysis. J Neurochem. 2012;122(2):233–43.
   PubMed Web of Science ®Google Scholar
• Chróinín DN, Asplund K, Åsberg S, Callaly E, Cuadrado-Godia E, Díez-Tejedor E, et al. Statin therapy and outcome after ischemic stroke systematic review and meta-analysis of observational studies and randomized trials. Stroke. 2013;44(2):448–56.
   PubMed Web of Science ®Google Scholar
• Asahi M, Huang Z, Thomas S, Yoshimura S-I, Sumii T, Mori T, et al. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia. J Cereb Blood Flow Metab. 2005;25(6):722–9.
   PubMed Web of Science ®Google Scholar
• Ye Y, Martinez JD, Perez-Polo RJ, Lin Y, Uretsky BF, Birnbaum Y. The role of eNOS, iNOS, and NF-κB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin. Am J Physiol Heart Circul Physiol. 2008;295(1):H343–H51.
   PubMed Web of Science ®Google Scholar
• Hong H, Zeng J-S, Kreulen DL, Kaufman DI, Chen AF. Atorvastatin protects against cerebral infarction via inhibition of NADPH oxidase-derived superoxide in ischemic stroke. Am J Physiol Heart Circul Physiol. 2006;291(5):H2210–H5.
   PubMed Web of Science ®Google Scholar
• Makabe S, Takahashi Y, Watanabe H, Murakami M, Ohba T, Ito H. Fluvastatin protects vascular smooth muscle cells against oxidative stress through the Nrf2-dependent antioxidant pathway. Atherosclerosis. 2010;213(2):377–84.
   PubMed Web of Science ®Google Scholar
• Moonis M. High-dose statins should be used in all acute ischemic strokes. Stroke. 2012;43(7):1992–3.
   PubMed Web of Science ®Google Scholar
• Golomb BA. Misinterpretation of trial evidence on statin adverse effects may harm patients. Eur J Prev Cardiol. 2015;22(4):492–3.
   PubMed Web of Science ®Google Scholar
• Hougaard KD, Hjort N, Zeidler D, Sørensen L, Nørgaard A, Hansen TM, et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke a randomized trial. Stroke 2014;45(1):159–67.
   PubMed Web of Science ®Google Scholar
• Lankin V, Tikhaze A, Konovalova G, Tutunov V, Medvedeva N, Kotkina T, et al. Intensification of free radical oxidation of low-density lipoproteins in the plasma of patients with ischemic heart disease receiving beta-hydroxy-beta-methylglutaryl-coenzyme a reductase inhibitor cerivastatin and inhibition of low-density lipoprotein peroxidation with antioxidant probucol. Bull Exp Biol Med 2002;134(1):39–42.
   PubMed Web of Science ®Google Scholar
• Kurata T, Lukic V, Kozuki M, Wada D, Miyazaki K, Morimoto N, et al. Long-term effect of telmisartan on Alzheimer’s amyloid genesis in SHR-SR after tMCAO. Translational Stroke Res 2015;6(2):107–15.
   PubMed Web of Science ®Google Scholar
• Simani L, Naderi N, Khodagholi F, Mehrpour M, Nasoohi S. Association of long-term atorvastatin with escalated stroke-induced neuroinflammation in rats. J Mol Neurosci 2016:1–10.
   Web of Science ®Google Scholar
• März P, Otten U, Miserez AR. Statins induce differentiation and cell death in neurons and astroglia. Glia 2007;55(1):1–12.
   PubMed Web of Science ®Google Scholar
• Martino A, Ettorre M, Musilli M, Lorenzetto E, Buffelli M, Diana G. Rho GTPase-dependent plasticity of dendritic spines in the adult brain. Front Cell Neurosci 2013;7:62.
   PubMed Web of Science ®Google Scholar
• Johnson-Anuna LN, Eckert GP, Keller JH, Igbavboa U, Franke C, Fechner T, et al. Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex. J Pharmacol Exp Therap 2005;312(2):786–93.
   PubMed Web of Science ®Google Scholar
• Sierra S, Ramos MC, Molina P, Esteo C, Vázquez JA, Burgos JS. Statins as neuroprotectants: a comparative in vitro study of lipophilicity, blood-brain-barrier penetration, lowering of brain cholesterol, and decrease of neuron cell death. J Alzheimer’s Dis 2011;23(2):307–18.
   PubMed Web of Science ®Google Scholar
• Wolozin B, Wang SW, Li N-C, Lee A, Lee TA, Kazis LE. Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease. BMC Med 2007;5(1):1.
   PubMedGoogle Scholar
• Langsjoen PH, Langsjoen AM. The clinical use of HMG CoA-reductase inhibitors and the associated depletion of coenzyme Q 10. A review of animal and human publications. Biofactors 2003;18(1–4):101–11.
   PubMed Web of Science ®Google Scholar
• Caso G, Kelly P, McNurlan MA, Lawson WE. Effect of coenzyme Q10 on myopathic symptoms in patients treated with statins. Am J Cardiol 2007;99(10):1409–12.
   PubMed Web of Science ®Google Scholar
• Mabuchi H, Nohara A, Kobayashi J, Kawashiri M-A, Katsuda S, Inazu A, et al. Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: a randomized double-blind study. Atherosclerosis 2007;195(2):e182–e9.
   PubMed Web of Science ®Google Scholar
• Rundek T, Naini A, Sacco R, Coates K, DiMauro S. Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke. Arch Neurol 2004;61(6):889–92.
   PubMedGoogle Scholar
• Hargreaves I, Duncan A, Heales S, Land J. The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications. Drug Safety 2005;28(8):659–76.
   PubMed Web of Science ®Google Scholar
• Chen J, Zhang C, Jiang H, Li Y, Zhang L, Robin A, et al. Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice. J Cereb Blood Flow Metab 2005;25(2):281–90.
   PubMed Web of Science ®Google Scholar
• Passi S, De Pità O, Puddu P, Littarru GP. Lipophilic antioxidants in human sebum and aging. Free Radical Res 2002;36(4):471–7.
   PubMed Web of Science ®Google Scholar
• McKenney JM. Pharmacologic characteristics of statins. Clin Cardiol 2003;26(S3):32–8.
   Google Scholar
• Banach M, Serban C, Ursoniu S, Rysz J, Muntner P, Toth PP, et al. Statin therapy and plasma coenzyme Q10 concentrations—a systematic review and meta-analysis of placebo-controlled trials. Pharmacol Res 2015;99:329–36.
   PubMed Web of Science ®Google Scholar
• Dietschy JM, Turley SD. Cholesterol metabolism in the brain. Cur Opin Lipidol 2001;12(2):105–12.
   PubMed Web of Science ®Google Scholar
• Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA. Statins and the risk of dementia. Lancet 2000;356(9242):1627–31.
   PubMed Web of Science ®Google Scholar
• Kwong LK, Kamzalov S, Rebrin I, Bayne A-CV, Jana CK, Morris P, et al. Effects of coenzyme Q 10 administration on its tissue concentrations, mitochondrial oxidant generation, and oxidative stress in the rat. Free Radic Biol Med 2002;33(5):627–38.
   PubMed Web of Science ®Google Scholar
• Bhagavan HN, Chopra RK. Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res 2006;40(5):445–53.
   PubMed Web of Science ®Google Scholar
• Adibhatla RM, Hatcher JF. Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antiox Redox Sig 2010;12(1):125–69.
   PubMed Web of Science ®Google Scholar
• Belousova M, Tokareva OG, Gorodetskaya E, Kalenikova EI, Medvedev OS. Intravenous treatment with coenzyme Q10 improves neurological outcome and reduces infarct volume after transient focal brain ischemia in rats. J Cardiovas Pharmacol 2016;67(2):103–9.
   PubMed Web of Science ®Google Scholar
• Li G, Zou L, Jack CR, Yang Y, Yang ES. Neuroprotective effect of coenzyme Q10 on ischemic hemisphere in aged mice with mutations in the amyloid precursor protein. Neurobiol Aging 2007;28(6):877–82.
   PubMed Web of Science ®Google Scholar
• Grieb P, Ryba MS, Sawicki J, Chrapusta SJ. Oral coenzyme Q10 administration prevents the development of ischemic brain lesions in a rabbit model of symptomatic vasospasm. Acta Neuropathol 1997;94(4):363–8.
   PubMed Web of Science ®Google Scholar
• Ying M, Sui X, Zhang Y, Sun Q, Qu Z, Luo X, et al. Identification of novel key molecules involved in spatial memory impairment in triple transgenic mice of Alzheimer’s disease. Mol Neurobiol 2016:1–16.
   PubMed Web of Science ®Google Scholar
• Littarru GP, Tiano L. Bioenergetic and antioxidant properties of coenzyme Q10: recent developments. Mol Biotechnol 2007;37(1):31–7.
   PubMed Web of Science ®Google Scholar
• Lee B-J, Tseng Y-F, Yen C-H, Lin P-T. Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial. Nutr J 2013;12(1):1.
   PubMedGoogle Scholar
• Sanoobar M, Eghtesadi S, Azimi A, Khalili M, Khodadadi B, Jazayeri S, et al. Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial. Nutr Neurosci 2015;18(4):169–76.
   PubMed Web of Science ®Google Scholar
• Schmelzer C, Kubo H, Mori M, Sawashita J, Kitano M, Hosoe K, et al. Supplementation with the reduced form of Coenzyme Q10 decelerates phenotypic characteristics of senescence and induces a peroxisome proliferator-activated receptor-α gene expression signature in SAMP1 mice. Mol Nutr Food Res 2010;54(6):805–15.
   PubMed Web of Science ®Google Scholar
• Schmelzer C, Lindner I, Rimbach G, Niklowitz P, Menke T, Döring F. Functions of coenzyme Q10 in inflammation and gene expression. Biofactors 2008;32(1–4):179–83.
   PubMed Web of Science ®Google Scholar
• Schmelzer C, Lorenz G, Rimbach G, Döring F. In vitro effects of the reduced form of coenzyme Q10 on secretion levels of TNF-α and chemokines in response to LPS in the human monocytic cell line THP-1. J Clin Biochem Nutr 2009;44(1):62–6.
   PubMed Web of Science ®Google Scholar
• Zhang YP, Eber A, Yuan Y, Yang Z, Rodriguez Y, Levitt RC, et al. Prophylactic and antinociceptive effects of coenzyme Q10 on diabetic neuropathic pain in a mouse model of type 1 diabetes. J Am Soc Anesthesiol 2013;118(4):945–54.
   PubMed Web of Science ®Google Scholar
• Díaz-Castro J, Guisado R, Kajarabille N, García C, Guisado IM, de Teresa C, et al. Coenzyme Q10 supplementation ameliorates inflammatory signaling and oxidative stress associated with strenuous exercise. Eur J Nutr. 2012;51(7):791–9.
   PubMed Web of Science ®Google Scholar
• Brauner H, Lüthje P, Grünler J, Ekberg N, Dallner G, Brismar K, et al. Markers of innate immune activity in patients with type 1 and type 2 diabetes mellitus and the effect of the anti-oxidant coenzyme Q10 on inflammatory activity. Clin Exp Immunol 2014;177(2):478–82.
   PubMed Web of Science ®Google Scholar
• Park J, Park H-H, Choi H, Kim YS, Yu H-J, Lee K-Y, et al. Coenzyme Q10 protects neural stem cells against hypoxia by enhancing survival signals. Brain Res 2012;1478:64–73.
   PubMed Web of Science ®Google Scholar